PPARGC1A and fatty liver disease: In summary, supplementation with GTB1TM could relieve energy-metabolic stress by modulating PPAR/PGC1α signaling in adipose tissues, which contributes to improvements to dysregulated metabolism features, including excessive adiposity, insulin resistance, hepatic steatosis, and hyperlipidemia.